Get the Stockscreener App
0.6901
9.35%
-0.0712
After Hours:
.69
-0.0001
-0.01%
Tela Bio Inc stock is traded at $0.6901, with a volume of 574.90K.
It is down -9.35% in the last 24 hours and down -18.61% over the past month.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
See More
Previous Close:
$0.7613
Open:
$0.761
24h Volume:
574.90K
Relative Volume:
3.38
Market Cap:
$30.73M
Revenue:
$77.06M
Net Income/Loss:
$-39.00M
P/E Ratio:
-0.7783
EPS:
-0.8867
Net Cash Flow:
$-31.50M
1W Performance:
-4.15%
1M Performance:
-18.61%
6M Performance:
-53.37%
1Y Performance:
-44.35%
1-Day Range:
$0.62
$0.7665
1-Week Range:
$0.62
$0.899
52-Week Range:
$0.62
$2.20
Tela Bio Inc Stock (TELA) Company Profile
Name
Tela Bio Inc
Sector
Industry
Phone
484-320-2930
Address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.6901 | 33.90M | 77.06M | -39.00M | -31.50M | -0.8867 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-31-22 | Initiated | Lake Street | Buy |
| Dec-03-19 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | JMP Securities | Mkt Outperform |
| Dec-03-19 | Initiated | Jefferies | Buy |
| Dec-03-19 | Initiated | Piper Jaffray | Overweight |
View All
Tela Bio Inc Stock (TELA) Latest News
TELA Bio Analysts Cut Their Forecasts After Q4 Results - Benzinga
TELA Bio 10-K: Revenue $80.3M, Net Loss $38.8M - TradingView
TELA Bio (NASDAQ: TELA) grows 2025 revenue 16% while investing heavily in R&D - Stock Titan
Piper Sandler Lowers Price Target for TELA Bio (TELA) to $1.00 | - GuruFocus
TELA Bio net loss hits USD 9M in Q4 2025 - Medical Buyer
TELA Bio, Inc. (NASDAQ:TELA) Q4 2025 earnings call transcript - MSN
TELA Bio (TELA) Rating Maintained but Price Target Lowered by An - GuruFocus
Piper Sandler cuts TELA Bio stock price target on lowered outlook - Investing.com India
Analyst Maintains 'Buy' Rating for TELA, Lowers Price Target to $2.00 | TELA Stock News - GuruFocus
Jefferies cuts TELA Bio stock price target on slower growth outlook - Investing.com India
TELA Bio, Inc. (NASDAQ:TELA) Q4 2025 Earnings Call Transcript - Insider Monkey
TELA Bio Inc (TELA) Q4 2025 Earnings Call Highlights: Record Rev - GuruFocus
Tela Bio targets at least 8% revenue growth in 2026 while advancing commercial transformation - MSN
Tela Bio Earnings Call: Growth Momentum, Cautious Outlook - TipRanks
TELA Bio, Inc. (TELA) Announces Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget
TELA Bio (TELA) Q4 2025 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: TELA Bio Q4 2025 surprises with EPS beat but revenue miss - Investing.com
TelaBio (TELA) Reports Record Quarterly Revenue in Q4 - GuruFocus
TELA Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView
TELA Bio Q4 Net Loss Narrows, Revenue Rises - marketscreener.com
TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
TELA Sees Growth with FY26 Revenue Projected to Rise at Least 8% - GuruFocus
TELA Bio, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
TELA Bio Posts Record 2025 Revenue, Sets 2026 Outlook - TipRanks
TELA BIO ($TELA) Releases Q4 2025 Earnings - Quiver Quantitative
TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
TELA Bio (NASDAQ: TELA) lifts 2025 sales 16% but posts $38.8M loss - Stock Titan
Medical device maker secures up to $70M after 18% sales gain - Stock Titan
TELA Bio Inc (TELA) Q4 2025: Everything You Need To Know Ahead O - GuruFocus
If You Invested $1,000 in Tela Bio, Inc. (TELA) - Stock Titan
TELA Bio Awards Inducement Equity Grants to New Employees - MSN
TELA Bio to report fourth quarter and full-year 2025 results March 24 - MSN
TELA Bio Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
TELA Bio Receives Nasdaq Deficiency Notice on Listing - TipRanks
TELA Bio Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
TELA Bio (TELA) hit with Nasdaq $1 bid-price deficiency, faces delisting risk - Stock Titan
TELA Bio Reports Q1 2025 Growth and Product Expansion - MSN
TELA Bio to Present at the 2025 Jefferies Global Healthcare Conference - MSN
Aug Wrap: What analysts say about TELA Bio Inc stockLayoff News & Weekly Market Pulse Alerts - baoquankhu1.vn
TELA Bio Posts Steady Growth as Strategic Shift Sparks New Commercial Momentum - MSN
TELA Bio (TELA) Projected to Post Quarterly Earnings on Tuesday - Defense World
TELA Bio to Report Fourth Quarter and Full-Year 2025 Results March 24 - MyChesCo
IPO Launch: What is TELA Bio Incs revenue forecast2026 Reactions & Fast Momentum Entry Tips - baoquankhu1.vn
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results - 富途牛牛
Trend Report: Can TELA Bio Inc deliver alpha2026 AllTime Highs & Fast Gain Swing Alerts - baoquankhu1.vn
TELA Bio (NASDAQ: TELA) CMO details stock and option holdings - Stock Titan
TELA Bio to Present at Canaccord Genuity 45th Annual Growth Conference - MSN
Performance Recap: What is TELA Bio Incs revenue forecastJuly 2025 Trends & Free Community Consensus Stock Picks - baoquankhu1.vn
OviTex Reinforced Tissue Matrix designed for regeneration, TELA Bio asserts - Traders Union
Comparing TELA Bio (NASDAQ:TELA) & Quantum Genomics (OTCMKTS:QNNTF) - Defense World
TELA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Tela Bio Inc Stock (TELA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):